Skip to main content
Premium Trial:

Request an Annual Quote

Anthony Mattacchione

Bruker has named Anthony Mattacchione its new CFO, effective immediately. He has served as the firm's interim CFO since June 2015 and previously was Bruker's SVP of finance and accounting. Before joining Bruker, Mattacchione was CFO of EMD Millipore, a subsidiary of Germany's Merck KGaA. From 2006 to 2010, he served as controller and chief accounting officer for Millipore.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.